News
Media
Conferences
Events
Partners
Publications
Resources
Biomarker Consortium
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Nasser Khaled Altorki, MD

Articles by Nasser Khaled Altorki, MD

Nasser Khaled Altorki, MD

Dr. Altorki on the Results of Post-Hoc Analyses of the IMpower010 Trial in NSCLC

ByNasser Khaled Altorki, MD

September 30th 2021

Nasser Khaled Altorki, MD, discusses the results of post-hoc analyses of the phase 3 IMpower010 trial in non–small cell lung cancer.

Latest Updated Articles

Dr. Altorki on the Results of Post-Hoc Analyses of the IMpower010 Trial in NSCLC
Published: September 30th 2021 | Updated:

Trending on OncLive

Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma

Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer

Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies

FDA Approves Larger Vial Size for Nelarabine Injection in T-ALL and T-LBL

Oncology Fellows Highlights 2025 ESMO Fellowship Winners